NETO2 and cancer: Upregulation of NETO2 enhances cancer progression by activating PI3K/AKT- and ERK/MAPK-dependent cascades and downstream transcription factors such as NF-κB, Snail, and Nrf2, thereby promoting epithelial–mesenchymal transition, proliferation, migration, and invasion [44,45].